UK markets closed

Eagle Pharmaceuticals, Inc. (EGRX)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
4.1900+0.1000 (+2.44%)
At close: 04:00PM EDT
4.1300 -0.06 (-1.43%)
After hours: 04:18PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
55,321
97,659
103,155
Total cash
55,321
97,659
103,155
Net receivables
72,439
41,149
51,117
Inventory
47,794
21,908
8,075
Other current assets
3,259
1,400
1,605
Total current assets
188,754
172,606
166,065
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
7,769
7,591
7,268
Accumulated depreciation
-6,601
-5,955
-5,191
Net property, plant and equipment
1,168
1,636
2,077
Goodwill
45,033
39,743
39,743
Intangible assets
118,327
10,671
12,917
Other long-term assets
25,732
10,278
17,208
Total non-current assets
217,406
81,126
87,125
Total assets
406,160
253,732
253,190
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
6,250
25,607
8,000
Accounts payable
18,993
16,431
6,268
Taxes payable
5,182
0
-
Accrued liabilities
46,081
19,767
16,698
Other current liabilities
10,842
6,177
1,952
Total current liabilities
111,087
74,376
38,085
Non-current liabilities
Long-term debt
56,216
-
25,135
Other long-term liabilities
5,297
2,903
3,959
Total non-current liabilities
61,513
2,903
29,094
Total liabilities
172,600
77,279
67,179
Stockholders' equity
Common stock
18
17
17
Retained earnings
111,504
75,862
84,489
Accumulated other comprehensive income
-1,112
-94
0
Total stockholders' equity
233,560
176,453
186,011
Total liabilities and stockholders' equity
406,160
253,732
253,190